SCHEMBL23536723

SCHEMBL23536723

Cc1c(CC=O)cccc1C(F)(F)F

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CTSS P25774 1/20 0.43
P2RX7 Q99572 6/20 0.41
TAS2R14 Q9NYV8 1/20 0.39
CYP2D6 P10635 1/20 0.39
SLC6A2 P23975 1/20 0.39
SLC6A4 P31645 1/20 0.39
KCNH2 Q12809 1/20 0.39
SCN8A Q9UQD0 1/20 0.38
IDO1 P14902 2/20 0.38
NOTUM Q6P988 1/20 0.38
AR P10275 1/20 0.37
POLQ O75417 1/20 0.36
CMA1 P23946 2/20 0.36
PIK3CD O00329 2/20 0.36
PIK3CA P42336 2/20 0.36
PIK3CB P42338 2/20 0.36
PIK3CG P48736 2/20 0.36
KDM4E B2RXH2 1/20 0.36
ALDH1A1 P00352 1/20 0.36
GAA P10253 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL169420 0.82 IDO1 (0.50) IDO1ARPOLQKDM4EALDH1A1
SCHEMBL31751977 0.82 GABRA1 (0.46) CTSSP2RX7TAS2R14CYP2D6SLC6A2
SCHEMBL11967099 0.82 GABRA1 (0.46) CTSSP2RX7TAS2R14CYP2D6SLC6A2
SCHEMBL377351 0.81 AKR1B1 (0.43) CTSSP2RX7IDO1
SCHEMBL6862729 0.81 IDO1 (0.38) CTSSSCN8AIDO1POLQCMA1
SCHEMBL2360363 0.80 GABRA1 (0.41) CTSSSLC6A2SLC6A4IDO1AR
SCHEMBL13437613 0.80 P2RX7 (0.42) CTSSP2RX7SLC6A2SLC6A4
SCHEMBL18753207 0.79 IDO1 (0.41) CTSSP2RX7TAS2R14CYP2D6SLC6A2
SCHEMBL4550354 0.77 MAOB (0.45) P2RX7TAS2R14CYP2D6SLC6A2SLC6A4
SCHEMBL737569 0.77 PDCD1 (0.48) CTSSP2RX7TAS2R14CYP2D6SLC6A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4110333-A1 SOS1 INHIBITORS Mirati Therapeutics, Inc. (US) 2023-01-04 EP disclosed
EP-4076418-A1 SOS1 INHIBITORS Mirati Therapeutics, Inc. (US) 2022-10-26 EP disclosed
WO-2022187236-A1 NOVEL SUBSTITUTED TRICYCLIC AZA-HETEROCYCLES AS SOS1 INHIBITORS VIVA STAR BIOSCIENCES (SUZHOU) CO., LTD. (CN) 2022-09-09 WO disclosed
WO-2021127429-A1 SOS1 INHIBITORS Mirati Therapeutics, Inc. (US) 2021-06-24 WO disclosed